UK markets closed

Akari Therapeutics, Plc (AKTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.4050+0.1250 (+9.77%)
As of 03:47PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2023)Next year (2024)
No. of analysts0000
Avg. Estimate0000
Low estimate0000
High estimate0000
Year ago EPSN/AN/AN/AN/A
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2023)Next year (2024)
No. of analysts1111
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings historyInvalid DateInvalid DateInvalid Date30/03/2021
Est. EPSN/AN/AN/A0
Actual EPSN/AN/AN/A0
DifferenceN/AN/AN/A0
Surprise %N/AN/AN/AN/A
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2023)Next year (2024)
Current estimate0000
7 days ago-1-1-4-3.4
30 days ago-1-1-4-3.4
60 days ago-1-1-4-3.4
90 days ago-1-1-4-3.4
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesAKTXIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current yearN/AN/AN/AN/A
Next yearN/AN/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A